Richard Charles Coulon
Directeur Général chez Accuitis, Inc.
Profil
Richard Charles Coulon is currently the President, Chief Executive Officer & Director at Accuitis, Inc. He previously worked as the Executive Vice President-Sales & Marketing at Auriga Laboratories, Inc. Coulon completed his undergraduate degree at Michigan State University.
Postes actifs de Richard Charles Coulon
| Sociétés | Poste | Début |
|---|---|---|
Accuitis, Inc.
 Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | Directeur Général | - |
Anciens postes connus de Richard Charles Coulon
| Sociétés | Poste | Fin |
|---|---|---|
Auriga Laboratories, Inc.
 Auriga Laboratories, Inc. BiotechnologyHealth Technology Auriga Laboratories, Inc. is a specialty pharmaceutical company, which is engaged in the commercialization, licensing and development of prescription pharmaceutical products. Its products are focused in the respiratory, dermatology CNS and anti-infective therapeutic categories and are marketed to primary care physicians, pediatricians, dermatologists, urologists, psychiatrists and rheumatologists. The company was founded on April 12, 2005 and is headquartered in Camarillo, CA. | Sales & Marketing | - |
Formation de Richard Charles Coulon
| Michigan State University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Auriga Laboratories, Inc.
Auriga Laboratories, Inc. BiotechnologyHealth Technology Auriga Laboratories, Inc. is a specialty pharmaceutical company, which is engaged in the commercialization, licensing and development of prescription pharmaceutical products. Its products are focused in the respiratory, dermatology CNS and anti-infective therapeutic categories and are marketed to primary care physicians, pediatricians, dermatologists, urologists, psychiatrists and rheumatologists. The company was founded on April 12, 2005 and is headquartered in Camarillo, CA. | Health Technology |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | Health Technology |
